Abiomed ABMD
-
6 Small Cap Stocks With Plenty Of Cash On Hand And Strong Expected Growth
By ZetaKap : Small-cap stocks tend to offer investors greater growth opportunities than large-cap alternatives, although this comes with its fair share of added risk. Are you looking for small-caps? Do you feel better knowing your favorite companies have enough cash to cover their operating ...
-
Lazard downgrades Abiomed on Impella reimbursement concerns
(Reuters) - Shares in medical device maker Abiomed Inc could remain under pressure due to concerns about any possible reimbursement issue with its Impella heart pump, said brokerage Lazard Capital...
-
Abiomed forecasts revenue above estimates, shares jump
(Reuters) - Medical device maker Abiomed Inc posted a quarterly profit that met analysts' expectations and forecast a fiscal 2013 revenue above market estimates, sending its shares up 5 percent.
-
UPDATE 1- Abiomed forecasts revenue above estimates, shares jump
May 16 (Reuters) - Medical device maker Abiomed Inc posted a quarterly profit that met analysts' expectations and forecast a fiscal 2013 revenue above market estimates, sending its shares up 5 percent.
-
Premarket gainers: [[OSUR]] +30%. [[COGO]] +15%. [[SINA]] +12%. [[ ABMD ]] +9%. [[VELT]] +8%. [[FTR]] +6%. Losers: [[CLNT]] -29%. [[JCP]] -15%. [[TAXI]] -9%. [[NBG]] -8%. [[ANF]] -7%. [[ARNA]] -6%. ...
Premarket gainers: OSUR +30% . COGO +15% . SINA +12% . ABMD +9% . VELT +8% . FTR +6% . Losers: CLNT -29% . JCP -15% . TAXI -9% . NBG -8% . ANF -7% . ARNA -6% . WHX -5% . KERX -5% . Post your comment!
-
Abiomed Accelerates Growth
Abiomed ABMD turned in excellent fourth-quarter results ..... major update. In general, we believe Abiomed 's shares are trading at acquisition ..... chosen markets. During the quarter, Abiomed 's growth accelerated after being included …
-
New Morningstar Analyst Report - Abiomed
Abiomed 's prospects largely rely on products ..... marketplace for a variety of reasons. Abiomed has a lot on its plate, and the organization ..... fish in the large medical device market, Abiomed may find it difficult to expand its reach …
-
ABIOMED ( ABMD ): Q1 EPS of $0.07 in-line. Revenue of $37.3M (+30.9% Y/Y) beats by $2.3M. (PR)
ABIOMED ( ABMD ): Q1 EPS of $0.07 in-line. Revenue of $37.3M (+30.9% Y/Y) beats by $2.3M . ( PR ) Post your comment!
-
Abiomed , Inc. ABMD Q4 2012 Earnings Call Transcript
… ladies and gentlemen and welcome to the Abiomed Fourth Quarter Fiscal 2012 Earnings Conference ..... Good morning everyone and welcome to Abiomed 's fourth quarter fiscal 2012 earnings ..... Lisa and I'm here with Mike Minogue, Abiomed 's Chairman, President and Chief Executive …
-
Thoratec Competitor Gets FDA Panel Nod
… destination therapy with this new competition. In 2014, Thoratec may be able to introduce a new acute VAD to compete with Abiomed 's ABMD Impella product set, which could boost growth modestly. Beyond that, we could see Thoratec's growth re-accelerate …